ShopSpell

Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins [Paperback]

$96.99     $119.99    19% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1617372633
  • ISBN-10:  1617372633
  • ISBN-13:  9781617372636
  • ISBN-13:  9781617372636
  • Publisher:  Humana
  • Publisher:  Humana
  • Pages:  352
  • Pages:  352
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Mar-2010
  • Pub Date:  01-Mar-2010
  • SKU:  1617372633-11-SPRI
  • SKU:  1617372633-11-SPRI
  • Item ID: 105302010
  • List Price: $119.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Oct 01 to Oct 03
  • Notes: Brand New Book. Order Now.
In Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins, a panel of leading basic researchers, pharmaceutical scientists, and clinical oncologists explain in detail the therapeutically-relevant protein targets that contribute to cancer pathology and spell out their implications for cancer drug discovery and clinical application. The authors identify and illuminate selected transcription factor oncoproteins and tumor suppressors, together with nuclear proteins that are central to the phenotype of the tumor cell involved in chromatin control. The emphasis is on new targets and approaches to cancer treatment derived from the cancer cell cycle, gene control targets, and angiogenesis.Cancer Chemotherapy Based on E2F and the Retinoblastoma Pathway. Myc Oncoproteins as Targets for Therapeutic Intervention in Tumorigenesis. The AP-1 Family of Transcription Factors: Structure, Regulation, and Functional Analysis in Mice. Hypoxia-Induced Factor-1 as a Target for Anticancer Therapy. Nuclear b-Catenin Signaling as a Target for Anticancer Drug Development Histone Acetyltransferases as Potential Targets for Cancer Therapies. Histone Deacetylases. Cyclin-Dependent Kinases and Their Small-Molecule Inhibitors in Cancer Therapy. Mitogen-Activated Protein Kinase Cascades as Therapeutic Targets in Cancer. Mdm2 and ARF. The Breast Cancer Susceptibility Genes, BRCA1 and BRCA2. Human Papillomavirus Targets for Therapeutic Intervention. Apoptin as an Anticancer Therapy. E2F and Cancer Chemotherapy. Hypoxic Signaling Pathways as Targets for Anticancer Therapy. Androgen Receptor and Estrogen Receptors. Index.'This book will be of interest to drug development professionals and oncology researchers. Specific chapters make good reviews for clinicians interested in emerging therapies and may also be useful for students. - Today's Life Science

The book is included in the successful series of publications Cancer Drug Discovery and Development forlĂ&
Add Review